JP7673210B2 - 皮膚放射線傷害の予防及び治療のための組成物及び方法 - Google Patents

皮膚放射線傷害の予防及び治療のための組成物及び方法 Download PDF

Info

Publication number
JP7673210B2
JP7673210B2 JP2023542836A JP2023542836A JP7673210B2 JP 7673210 B2 JP7673210 B2 JP 7673210B2 JP 2023542836 A JP2023542836 A JP 2023542836A JP 2023542836 A JP2023542836 A JP 2023542836A JP 7673210 B2 JP7673210 B2 JP 7673210B2
Authority
JP
Japan
Prior art keywords
composition
radiation
cri
sertraline
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2023542836A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023544448A (ja
Inventor
エル.ハーディー レジナルト
ブリゲル ミッチェル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rythera Therapeutics Inc
Original Assignee
Rythera Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rythera Therapeutics Inc filed Critical Rythera Therapeutics Inc
Publication of JP2023544448A publication Critical patent/JP2023544448A/ja
Application granted granted Critical
Publication of JP7673210B2 publication Critical patent/JP7673210B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2023542836A 2020-09-22 2021-09-22 皮膚放射線傷害の予防及び治療のための組成物及び方法 Active JP7673210B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063081718P 2020-09-22 2020-09-22
US202063081547P 2020-09-22 2020-09-22
US63/081,718 2020-09-22
US63/081,547 2020-09-22
PCT/US2021/051583 WO2022066791A1 (fr) 2020-09-22 2021-09-22 Compositions et méthodes de prévention et de traitement de lésion cutanée radique

Publications (2)

Publication Number Publication Date
JP2023544448A JP2023544448A (ja) 2023-10-23
JP7673210B2 true JP7673210B2 (ja) 2025-05-14

Family

ID=80857195

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023542836A Active JP7673210B2 (ja) 2020-09-22 2021-09-22 皮膚放射線傷害の予防及び治療のための組成物及び方法

Country Status (7)

Country Link
EP (1) EP4217001A4 (fr)
JP (1) JP7673210B2 (fr)
AU (2) AU2021349237B2 (fr)
CA (1) CA3193398A1 (fr)
IL (1) IL301530A (fr)
MX (1) MX2023003357A (fr)
WO (1) WO2022066791A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2022351983A1 (en) * 2021-09-22 2024-04-18 Rythera Therapeutics Inc. Composition and method for prevention and treatment of cutaneous radiation injury
CN120091820A (zh) * 2022-09-22 2025-06-03 瑞特拉治疗公司 用于预防和治疗皮肤放射性损伤的组合物和方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030157086A1 (en) 2000-02-15 2003-08-21 Tilly Jonathan L. Protection of the female reproductive system from natural and artificial insults
JP2006524659A (ja) 2003-04-28 2006-11-02 ビーオフロンテラ バイオサイエンス ゲーエムベーハー ケラチノサイトの過剰増殖、特に、アトピー性皮膚炎および乾癬を特徴とする疾患を治療するためのリルゾールの使用
US20180050019A1 (en) 2015-03-06 2018-02-22 Repoceuticals Aps Melatonin for Preventing and Treating Radiation Vaginitis and Proctitis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19621038A1 (de) * 1996-05-24 1997-11-27 Boehringer Ingelheim Kg Aminoguanidine, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten
MXPA06012777A (es) * 2004-05-06 2007-02-14 Cydex Inc Formulaciones de sabor enmascarado que contienen sertralina y eter sulfoalquilico-ciclodextrina.
US7250445B1 (en) * 2005-01-14 2007-07-31 Ehrenpreis Eli D Anti-oxidant suppository for treating radiation proctopathy and other anorectal disorders
PT2114896E (pt) * 2006-12-21 2015-11-04 Peter Maccallum Cancer Inst Compostos radio-protetores e métodos relacionados
US20090156982A1 (en) * 2007-09-06 2009-06-18 Arezou Petrie Transdermal treatment device and method
US9616006B2 (en) * 2007-10-10 2017-04-11 DermaMedics, LLC Methods and compositions for treating dermatological diseases and conditions
US20150353912A1 (en) * 2012-05-31 2015-12-10 Children's Hospital Medical Center Methods for treating and preventing radiation injury using activated protein c polypeptides

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030157086A1 (en) 2000-02-15 2003-08-21 Tilly Jonathan L. Protection of the female reproductive system from natural and artificial insults
JP2006524659A (ja) 2003-04-28 2006-11-02 ビーオフロンテラ バイオサイエンス ゲーエムベーハー ケラチノサイトの過剰増殖、特に、アトピー性皮膚炎および乾癬を特徴とする疾患を治療するためのリルゾールの使用
US20180050019A1 (en) 2015-03-06 2018-02-22 Repoceuticals Aps Melatonin for Preventing and Treating Radiation Vaginitis and Proctitis

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Br. J. Clin. Pharmacol.,2020年02月,86(9),pp.1875-1881,doi: 10.1111/bcp.14238
Jpn. Dent. Sci. Rev.,2020年,56(1),pp.62-67,doi: 10.1016/j.jdsr.2020.02.001
日本放射線影響学会大会講演要旨集,2007年,Vol.50th ,Page.97, セッションID: CP-121,DOI:https://doi.org/10.11513/jrrsabst.2007.0.201.0

Also Published As

Publication number Publication date
IL301530A (en) 2023-05-01
WO2022066791A1 (fr) 2022-03-31
AU2025202935A1 (en) 2025-05-15
MX2023003357A (es) 2023-06-30
AU2021349237A1 (en) 2023-06-08
AU2021349237B2 (en) 2025-05-01
JP2023544448A (ja) 2023-10-23
EP4217001A4 (fr) 2024-04-24
EP4217001A1 (fr) 2023-08-02
CA3193398A1 (fr) 2022-03-31

Similar Documents

Publication Publication Date Title
AU2025202935A1 (en) Composition and method for prevention and treatment of cutaneous radiation injury
TW201615221A (zh) 炎症用藥臨床新應用
JP2007302657A (ja) 痙症の兆候および症候の緩和方法
US20020049188A1 (en) Nitroglycerin ointment for treatment of pain associated with anal disease
CN104338147A (zh) 一种用于缓控释给药的软膏组合基质
AU2020298248A1 (en) Transdermal penetrant formulations
KR20240065134A (ko) 피부 방사선 손상의 예방 및 치료를 위한 조성물 및 방법
US11179353B1 (en) Composition and method for prevention and treatment of radiation dermatitis
WO2014176417A1 (fr) Préparation topique pour contourner un tractus gastro-intestinal, administration d'agents thérapeutiques et système d'administration de médicament trans-épithéliale
US11173111B1 (en) Composition and method for prevention and treatment of anorectal disorders
US20240342114A1 (en) Compositon and method for prevention and treatment of cutaneous radiation injury
US20250241904A1 (en) Composition and method for prevention and treatment of cutaneous radiation injury
KR20250069676A (ko) 궤양 예방 및/또는 치료를 위한 스틸벤 유도체의 용도
CN1414847A (zh) 含吡喹酮的缓释抗蠕虫组合物
CN118317792A (zh) 用于预防和治疗皮肤放射性损伤的组合物和方法
HK40113806A (zh) 用於预防和治疗皮肤放射性损伤的组合物和方法
RU2432942C1 (ru) Композиция для приготовления обладающей пролонгированным действием лекарственной формы для лечения орофарингеальной зоны
WO2024236533A1 (fr) Rutine, également appelée oxérutine, pour le traitement de l'épidermolyse bulleuse
EP4081540A1 (fr) Cyclosporine topique pour le traitement du psoriasis et d'autres maladies
JP2022540854A (ja) 疼痛を緩和するためのイブプロフェン及びトラマドールの組合せ
KR20060123329A (ko) 월경 곤란증의 예방 및/또는 치료제
Jost Treatment of anal fissure with botulinum toxin-A

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230602

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240528

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240827

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241029

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250129

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250415

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250423

R150 Certificate of patent or registration of utility model

Ref document number: 7673210

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150